两种术式治疗肝巨大血管瘤临床疗效比较*

doi:10.3969/j.issn.1672-5069.2018.06.032

实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (6): 959-962.doi: 10.3969/j.issn.1672-5069.2018.06.032

两种术式治疗肝巨大血管瘤临床疗效比较^*

郑学华, 张阳光, 曾禹李洪永

628001 四川省广元市第三人民医院外一科（郑学华,张阳光,曾禹）; 四川中医药高等专科学校附属富临医院普外科（李洪永）

收稿日期:2017-10-27 出版日期:2018-11-10 发布日期:2018-12-25
作者简介:郑学华,男,35岁,大学本科,主治医师。E-mail：sir087883416@163.com
基金资助:
*四川省卫生与计划生育厅科研课题(编号：20132859)

Clinical efficacy of hepatectomy and extravascular exfoliation in treatment of patients with giant hepatic hemangioma

Zheng Xuehua, Zhang Yangguang, Zeng Yu, et al.

Department of General Surgery,Third People’s Hospital,Guangyuan 628001,Sichuan Province,China

Received:2017-10-27 Online:2018-11-10 Published:2018-12-25

摘要/Abstract

摘要： 目的探讨肝叶切除术和肝血管瘤包膜外剥脱术治疗肝巨大血管瘤患者的临床疗效。方法 2014年5月~2016年4月我院肝胆外科收治的82例肝巨大血管瘤患者,41例接受肝叶切除术,另41例接受肝血管瘤包膜外剥脱术治疗。随访1年。结果接受肿瘤剥脱和肝叶切除患者的手术时间分别为（2.3±1.1） h和（3.3±1.1） h、术中出血量分别为（885.2±387.5）ml和（1567.5±751.4） ml、术中输血量分别为（928.7±412.4） ml和（1896.4±852.4） ml、肝血流阻断时间分别为（21.4±9.6） min和（27.5±8.2） min,住院日分别为（14.2±3.2） d和（16.5±3.5）d（P均<0.05）;肿瘤剥脱和肝叶切除患者术后并发症发生率分别为14.6%和34.2%（P<0.05）;经术后随访1年,肝叶切除患者术后血管瘤复发1例,失访11例,其余29例血管瘤消失,肿瘤剥脱患者复发1例,失访8例,其余32例血管瘤消失。结论肝切除术和肝血管瘤包膜外剥脱术均能有效治疗肝巨大血管瘤,但肝血管瘤包膜外剥脱术具有操作简便、手术创伤小、出血量少、肝血流阻断时间短、术后恢复快和术后并发症少等优点。

关键词: 肝血管瘤, 肝叶切除术, 包膜外剥脱术, 治疗

Abstract: Objective To investigate the clinical efficacy of hepatectomy and extravascular exfoliation in treatment of patients with giant hepatic hemangioma. Methods The clinical data of 82 patients with giant hepatic hemangioma admitted to our hospital between May 2014 and April 2016 were retrospectively analyzed，and 41 patients received hepatectomy and another 41 received extravascular exfoliation. All patients were followed-up for one year. Results The operative time，intraoperative blood loss，intraoperative blood transfusion，hepatic blood flow blocking time and hospital stay were （2.3±1.1） h，（885.2±387.5） ml，（928.7±412.4） ml，（21.4±9.6） min and （14.2±3.2） d in patients receiving exfoliation and（3.3±1.1） h，（1567.5±751.4） ml，（1896.4±852.4） ml，（27.5±8.2） min and（16.5±3.5） d in patients receiving hepatectomy（all P<0.05）；the incidence rate of postoperative complications was 14.6% in patients receiving exfoliation and 34.2% in patients receiving hepatectomy （P<0.05）；at the end of 1 year follow-up，one patient had recurrent hepatic hemagioma，11 lost and 29 had hepatic hemagioma disappeared in patients receiving hepatectomy，and one had recurrent hemagioma，8 lost and 32 had hemagioma disappeared in patients receiving tumor exfoliation. Conclusions Hepatectomy and extravascular exfoliation can be applied to the removal of giant hepatic hemangioma，while the latter has the advantages of relatively simple operation，small surgical trauma，little blood loss，short liver blood flow blocking time，rapid postoperative recovery and few postoperative complications.

Key words: Hepatic hemangioma, Hepatectomy, Extravascular exfoliation, Therapy

郑学华, 张阳光, 曾禹李洪永. 两种术式治疗肝巨大血管瘤临床疗效比较^*[J]. 实用肝脏病杂志, 2018, 21(6): 959-962.

Zheng Xuehua, Zhang Yangguang, Zeng Yu, et al.. Clinical efficacy of hepatectomy and extravascular exfoliation in treatment of patients with giant hepatic hemangioma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 959-962.

参考文献

[1] 方靓,王文平,陈悦,等. 肝巨大血管瘤超声造影表现及其诊断. 中华超声影像学杂志,2015,24(3):232-236.
[2] Subastri A,Suyavaran A,Pb E,et al.Troxerutin with copper generates oxidative stress in cancer cells:its possible chemotherapeutic mechanism against hepatocellular carcinoma. J Cell Physiol,2017,233(3):1775-1790.
[3] Hann A,Osenda E,Reade J A,et al.Case report: successful open resection of a symptomatic giant liver haemangioma during the second trimester of pregnancy. J Surg Case Rep,2016,26(11):11-13.
[4] 肖年军,余强,段伟东,等. 肝血管瘤直径与手术风险的关系. 中华消化外科杂志,2015,14(9):737-740.
[5] Girotti P,Rolinger J,Kopp H G,et al.Gastrointestinal stromal tumours bigger than 20 cm:experience with imatinib chemotherapy in neoadjuvant intention. Zeitschrift Für Gastroenterologie,2014,52(1):50-54.
[6] Liu X,Yang Z,Tan H,et al.Characteristics and operative treatment of extremely giant liver hemangioma>20 cm. Surgery,2017,161(6):1514-1524.
[7] 符开伙,张剑权,蒋明. 腹腔镜下肝切除术治疗肝血管瘤临床研究. 实用肝脏病杂志,2016,19(6):709-712.
[8] Wang S,Gao J,Yang M,et al.Intratumoral coagulation by radiofrequency ablation facilitated the laparoscopic resection of giant hepatic hemangioma:a surgical technique report of two cases. Oncotarget,2017,8(31)::52006-52011.
[9] Li M,Zhang C,Zhang T,et al.Outcome using selective hemihepatic vascular occlusion and Pringle maneuver for hepatic resection of liver cavernous hemangioma. World J Surg Oncol,2015,13(1):267-272.
[10] Yang Y,Zhao LH,Fu SY,et al.Selective hepatic vascular exclusion versus pringle maneuver in partial hepatectomy for liver hemangioma compressing or involving the major hepatic veins. Am Surg,2014,80(3):236-240.
[11] Miyamoto S,Oshita A,Daimaru Y,et al.Hepatic sclerosed hemangioma:a case report and review of the literature. BMC Surg,2015,15(1):1-5.
[12] Li M,Zhang T,Wang L,et al.Selective hemihepatic vascular occlusion versus Pringle maneuver in hepatectomy for primary liver cancer. Med Sci Monitor Int Med J Ex Clin Res,2017,23:2203-2210.
[13] Wang C,Chen H,Sun L,et al.Cardiac cavernous hemangioma coexisting with pulmonary cavernous hemangiomas and giant hepatic hemangioma. Ann Thorac Surg,2017,103(2):e149-e152.
[14] Xu W,Xu HF,Yang H,et al.Continuous Pringle maneuver does not affect outcomes of patients with hepatocellular carcinoma after curative resection. Asia Pac J Clin Oncol,2016,13(5):e321-e330.
[15] Doussot A,Lim C,Gavara C G,et al.Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma. Bri J Surg,2016,103(13):1887-1895.
[16] Zhang W,Huang ZY,Ke CS,et al.Surgical treatment of giant liver hemangioma larger than 10 cm:A single center's experience with 86 patients. Medicine,2015,94(34):e1420.
[17] 柏斗胜,蒋国庆,陈平,等. 改良的腹腔镜下肝血管瘤切除术的临床应用. 中华普通外科杂志,2015,30(11):858-861.
[18] Jr BT,Gurzu S,Jung I,et al.Giant cavernous hepatic hemangioma diagnosed incidentally in a perimenopausal obese female with endometrial adenocarcinoma:A case report. Anticancer Res,2016,36(2):769-772.

两种术式治疗肝巨大血管瘤临床疗效比较^*

Clinical efficacy of hepatectomy and extravascular exfoliation in treatment of patients with giant hepatic hemangioma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[5]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[6]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[7]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[8]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[9]	金震, 周晓春, 马红霞. 椎旁阻滞联合全身麻醉对肝血管瘤切除术患者疼痛及术后恢复的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 908-911.
[10]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[11]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[12]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[13]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.
[14]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[15]	赵协山, 伍春瑢, 王春峰, 余积洁, 何青. 替诺福韦联合安络化纤丸治疗HBeAg阴性慢性乙型肝炎患者疗效及其血清肝纤维化指标的变化研究*[J]. 实用肝脏病杂志, 2019, 22(5): 644-647.